Investigating the role of Kinesin family in lung adenocarcinoma via integrated bioinformatics approach

[1]  A. Rahmani,et al.  Integrative Multiomics and Regulatory Network Analyses Uncovers the Role of OAS3, TRAFD1, miR-222-3p, and miR-125b-5p in Hepatitis E Virus Infection , 2022, Genes.

[2]  M. Kanehisa,et al.  KEGG for taxonomy-based analysis of pathways and genomes , 2022, Nucleic Acids Res..

[3]  Prithvi Singh,et al.  miR-495-3p regulates sphingolipid metabolic reprogramming to induce Sphk1/ceramide mediated mitophagy and apoptosis in NSCLC. , 2022, Free Radical Biology & Medicine.

[4]  Kang Zhang,et al.  Integrated single-cell RNA sequencing analysis reveals distinct cellular and transcriptional modules associated with survival in lung cancer , 2022, Signal Transduction and Targeted Therapy.

[5]  A. Lánczky,et al.  Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation , 2021, Journal of medical Internet research.

[6]  Zhaodong Li,et al.  KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma , 2021, Frontiers in Oncology.

[7]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[8]  Hui Li,et al.  Identification of KIF4A and its effect on the progression of lung adenocarcinoma based on the bioinformatics analysis , 2021, Bioscience reports.

[9]  Jian-Hua Fu,et al.  Identification of activated pathways in lung adenocarcinoma based on network strategy , 2020, Journal of cancer research and therapeutics.

[10]  Xiaole Shirley Liu,et al.  TIMER2.0 for analysis of tumor-infiltrating immune cells , 2020, Nucleic Acids Res..

[11]  Yiyan Lei,et al.  Combined evaluation of the expression status of CD155 and TIGIT plays an important role in the prognosis of LUAD (lung adenocarcinoma). , 2020, International immunopharmacology.

[12]  Jin-hai Tang,et al.  Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinoma. , 2019, Cancer letters.

[13]  Minoru Kanehisa,et al.  Toward understanding the origin and evolution of cellular organisms , 2019, Protein science : a publication of the Protein Society.

[14]  Yifang Zhou,et al.  Clinical Significance And Integrative Analysis Of Kinesin Family Member 18B In Lung Adenocarcinoma , 2019, OncoTargets and therapy.

[15]  D. Xie,et al.  Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial–mesenchymal transition via Akt/GSK3β signaling , 2019, Cancer science.

[16]  F. Grossi,et al.  Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds , 2019, Expert opinion on investigational drugs.

[17]  Erin L. Schenk,et al.  Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer , 2019, Front. Immunol..

[18]  D. Mochly‐Rosen,et al.  Targeting mitochondrial dysfunction and oxidative stress in heart failure: Challenges and opportunities , 2018, Free radical biology & medicine.

[19]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[20]  Yuan Qiao,et al.  Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma , 2018, Cellular Physiology and Biochemistry.

[21]  Q. Ye,et al.  Overexpression of KIF2A is Suppressed by miR-206 and Associated with Poor Prognosis in Ovarian Cancer , 2018, Cellular Physiology and Biochemistry.

[22]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[23]  Jian-zhong Wu,et al.  Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis , 2018, Cancer medicine.

[24]  J. Vilo,et al.  MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. , 2018, Epigenomics.

[25]  Chengfang Yao,et al.  The paradoxical role of tumor-infiltrating immune cells in lung cancer. , 2017, Intractable & rare diseases research.

[26]  Vladimir Gelfand,et al.  Moonlighting Motors: Kinesin, Dynein, and Cell Polarity. , 2017, Trends in cell biology.

[27]  Yingduan Cheng,et al.  Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer , 2017, Oncotarget.

[28]  Cheng Li,et al.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..

[29]  P. Sicinski,et al.  Cell cycle proteins as promising targets in cancer therapy , 2017, Nature Reviews Cancer.

[30]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[31]  Ahir Gopaldas.  Therapy , 2016, Indian Journal of Nuclear Medicine : IJNM : The Official Journal of the Society of Nuclear Medicine, India.

[32]  E. Uribe-Querol,et al.  Neutrophils in Cancer: Two Sides of the Same Coin , 2015, Journal of immunology research.

[33]  Yee Ming Lee,et al.  The impact of the Cancer Genome Atlas on lung cancer. , 2015, Translational research : the journal of laboratory and clinical medicine.

[34]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[35]  Tae-Min Kim,et al.  Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27Kip1 ubiquitination pathway in hepatocellular carcinoma , 2014, Experimental & Molecular Medicine.

[36]  X. J. Liu,et al.  Xenopus oocyte meiosis lacks spindle assembly checkpoint control , 2013, The Journal of cell biology.

[37]  H. Clarke,et al.  Regulation of mitochondrial DNA accumulation during oocyte growth and meiotic maturation in the mouse. , 2012, Reproduction.

[38]  Oliver Rath,et al.  Kinesins and cancer , 2012, Nature Reviews Cancer.

[39]  Sébastien Couraud,et al.  Lung cancer in never smokers--a review. , 2012, European journal of cancer.

[40]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[41]  Yue Yu,et al.  The role of kinesin family proteins in tumorigenesis and progression , 2010, Cancer.

[42]  Z. Szallasi,et al.  An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients , 2010, Breast Cancer Research and Treatment.

[43]  N. Hirokawa,et al.  Kinesin superfamily motor proteins and intracellular transport , 2009, Nature Reviews Molecular Cell Biology.

[44]  L. Tanoue,et al.  The new lung cancer staging system. , 2009, Chest.

[45]  Ping Yang,et al.  Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. , 2008, Mayo Clinic proceedings.

[46]  Bin Wang,et al.  Conventional kinesin holoenzymes are composed of heavy and light chain homodimers. , 2008, Biochemistry.

[47]  G A Colditz,et al.  Comparison of aspects of smoking among the four histological types of lung cancer , 2008, Tobacco Control.

[48]  T. Oshikiri,et al.  Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma , 2006, British Journal of Cancer.

[49]  F. Bray,et al.  International lung cancer trends by histologic type: Male:Female differences diminishing and adenocarcinoma rates rising , 2005, International journal of cancer.

[50]  Marina Bibikova,et al.  Functional analysis of human microtubule-based motor proteins, the kinesins and dyneins, in mitosis/cytokinesis using RNA interference. , 2005, Molecular biology of the cell.

[51]  Dennis B. Troup,et al.  NCBI GEO: mining millions of expression profiles—database and tools , 2004, Nucleic Acids Res..

[52]  N. Hirokawa,et al.  Kinesin superfamily proteins and their various functions and dynamics. , 2004, Experimental cell research.

[53]  P. Shannon,et al.  Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks , 2003 .

[54]  N. Hirokawa,et al.  All kinesin superfamily protein, KIF, genes in mouse and human , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[55]  G. C. Rogers,et al.  Microtubule motors in mitosis , 2000, Nature.

[56]  Peter A. Jones,et al.  Cancer-epigenetics comes of age , 1999, Nature Genetics.

[57]  N. Hirokawa,et al.  Kinesin and dynein superfamily proteins and the mechanism of organelle transport. , 1998, Science.

[58]  P. Laird.  Oncogenic mechanisms mediated by DNA methylation. , 1997, Molecular medicine today.

[59]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[60]  Michael P. Sheetz,et al.  Identification of a novel force-generating protein, kinesin, involved in microtubule-based motility , 1985, Cell.

[61]  Yu Bai,et al.  Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma. , 2019, Cancer biomarkers : section A of Disease markers.

[62]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[63]  Supplemental Information 2: Kyoto Encyclopedia of genes and genomes. , 2022 .